Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 97

1.

In vitro and in vivo investigation of cardiotoxicity associated with anticancer proteasome inhibitors and their combination with anthracycline.

Pokorna Z, Jirkovsky E, Hlavackova M, Jansova H, Jirkovska A, Lencova-Popelova O, Brazdova P, Kubes J, Sotakova-Kasparova D, Mazurova Y, Adamcova M, Vostatkova L, Holzerova K, Kolar F, Simunek T, Sterba M.

Clin Sci (Lond). 2019 Aug 27;133(16):1827-1844. doi: 10.1042/CS20190139. Print 2019 Aug 30.

PMID:
31409729
2.

Clinical and (31)P magnetic resonance spectroscopy characterization of patients with critical limb ischemia before and after autologous cell therapy.

Dubský M, Šedivý P, Němcová A, Drobný M, Hazdrová J, Fejfarová V, Bém R, Jirkovská A, Dezortová M, Hájek M.

Physiol Res. 2019 Aug 29;68(4):559-566. Epub 2019 Jun 6.

3.

Benefits of Acidifying Agents in Local Therapy of Diabetic Foot Ulcers Infected by Pseudomonas sp: A Pilot Study.

Fejfarová V, Tibenská H, Niklová J, Bém R, Dubský M, Wosková V, Němcová A, Jirkovská A, Jude E, Lánská V.

Int J Low Extrem Wounds. 2019 Sep;18(3):262-268. doi: 10.1177/1534734619848573. Epub 2019 Jun 3.

PMID:
31155991
4.

Impact of severe diabetic kidney disease on the clinical outcome of autologous cell therapy in people with diabetes and critical limb ischaemia.

Dubský M, Jirkovská A, Bem R, Němcová A, Fejfarová V, Hazdrová J, Sutoris K, Chlupáč J, Skibová J, Jude EB.

Diabet Med. 2019 Sep;36(9):1133-1140. doi: 10.1111/dme.13985. Epub 2019 Jun 13.

PMID:
31077439
5.

UHPLC-MS/MS method for analysis of sobuzoxane, its active form ICRF-154 and metabolite EDTA-diamide and its application to bioactivation study.

Reimerová P, Jirkovská A, Piskáčková HB, Karabanovich G, Roh J, Šimůnek T, Štěrbová-Kovaříková P.

Sci Rep. 2019 Mar 14;9(1):4524. doi: 10.1038/s41598-019-40928-5.

6.

Endothelial Progenitor Cells Biology in Diabetes Mellitus and Peripheral Arterial Disease and their Therapeutic Potential.

Pyšná A, Bém R, Němcová A, Fejfarová V, Jirkovská A, Hazdrová J, Jude EB, Dubský M.

Stem Cell Rev Rep. 2019 Apr;15(2):157-165. doi: 10.1007/s12015-018-9863-4. Review.

PMID:
30413930
7.

Detection and quantitation of iron in ferritin, transferrin and labile iron pool (LIP) in cardiomyocytes using 55Fe and storage phosphorimaging.

Krijt M, Jirkovska A, Kabickova T, Melenovsky V, Petrak J, Vyoral D.

Biochim Biophys Acta Gen Subj. 2018 Dec;1862(12):2895-2901. doi: 10.1016/j.bbagen.2018.09.005. Epub 2018 Sep 10.

PMID:
30279145
8.

Difference in Serum Endostatin Levels in Diabetic Patients with Critical Limb Ischemia Treated by Autologous Cell Therapy or Percutaneous Transluminal Angioplasty.

Nemcova A, Jirkovska A, Dubsky M, Kolesar L, Bem R, Fejfarova V, Pysna A, Woskova V, Skibova J, Jude EB.

Cell Transplant. 2018 Sep;27(9):1368-1374. doi: 10.1177/0963689718775628. Epub 2018 Jun 4.

9.

Perfusion scintigraphy in the assessment of autologous cell therapy in diabetic patients with critical limb ischemia.

Nemcova A, Jirkovska A, Dubsky M, Bem R, Fejfarova V, Woskova V, Pysna A, Buncova M.

Physiol Res. 2018 Aug 16;67(4):583-589. Epub 2018 May 10.

10.

Pharmacokinetics of the Cardioprotective Drug Dexrazoxane and Its Active Metabolite ADR-925 with Focus on Cardiomyocytes and the Heart.

Jirkovský E, Jirkovská A, Bureš J, Chládek J, Lenčová O, Stariat J, Pokorná Z, Karabanovich G, Roh J, Brázdová P, Šimůnek T, Kovaříková P, Štěrba M.

J Pharmacol Exp Ther. 2018 Mar;364(3):433-446. doi: 10.1124/jpet.117.244848. Epub 2017 Dec 22.

PMID:
29273587
11.

Investigation of novel dexrazoxane analogue JR-311 shows significant cardioprotective effects through topoisomerase IIbeta but not its iron chelating metabolite.

Bures J, Jirkovska A, Sestak V, Jansova H, Karabanovich G, Roh J, Sterba M, Simunek T, Kovarikova P.

Toxicology. 2017 Dec 1;392:1-10. doi: 10.1016/j.tox.2017.09.012. Epub 2017 Sep 21.

PMID:
28941780
12.

[Diabetic foot syndrome: importance of calf muscles MR spectroscopy in the assessment of limb ischemia and effect of revascularization].

Němcová A, Dubský M, Jirkovská A, Šedivý P, Drobný M, Hájek M, Dezortová M, Bém R, Fejfarová V, Pyšná A.

Vnitr Lek. Spring 2017;63(4):236-241. Czech.

PMID:
28520446
13.

Diabetic complications do not hamper improvement of health-related quality of life over the course of treatment of diabetic foot ulcers - the Eurodiale study.

Siersma V, Thorsen H, Holstein PE, Kars M, Apelqvist J, Jude EB, Piaggesi A, Bakker K, Edmonds M, Jirkovská A, Mauricio D, Reike H, Spraul M, Uccioli L, Urbancic V, van Acker K, van Baal J, Schaper NC.

J Diabetes Complications. 2017 Jul;31(7):1145-1151. doi: 10.1016/j.jdiacomp.2017.04.008. Epub 2017 Apr 13.

PMID:
28457703
14.

Cell therapy of critical limb ischemia in diabetic patients - State of art.

Dubský M, Jirkovská A, Bem R, Nemcová A, Fejfarová V, Jude EB.

Diabetes Res Clin Pract. 2017 Apr;126:263-271. doi: 10.1016/j.diabres.2017.02.028. Epub 2017 Feb 27. Review.

PMID:
28288436
15.

[Has been changed numbers and characteristics of patients with major amputations indicated for the diabetic foot in our department during last decade?]

Fejfarová V, Jirkovská A, Petkov V, Řezaninová L, Bém R, Dubský M, Wosková V, Němcová A, Skibová J.

Vnitr Lek. Winter 2016;62(12):969-975. Czech.

PMID:
28139125
16.

The relationship between chronic venous insufficiency and diabetes mellitus.

Fejfarová V, Roztočil K, Svědínková A, Čermáková H, Dubský M, Bém R, Jirkovská A, Wosková V, Němcová A, Skibová J.

Int Angiol. 2017 Feb;36(1):90-91. doi: 10.23736/S0392-9590.16.03736-6. No abstract available.

17.

An Alteration of Lymphocytes Subpopulations and Immunoglobulins Levels in Patients with Diabetic Foot Ulcers Infected Particularly by Resistant Pathogens.

Fejfarová V, Jirkovská A, Dubský M, Game F, Vydláková J, Sekerková A, Franeková J, Kučerová M, Stříž I, Petkov V, Bém R, Wosková V, Němcová A, Skibová J.

J Diabetes Res. 2016;2016:2356870. doi: 10.1155/2016/2356870. Epub 2016 Dec 5.

18.

Neonatal capsaicin administration impairs postnatal development of the cardiac chronotropy and inotropy in rats.

Kuncová J, Jirkovská A, Švíglerová J, Marková M, Meireles D, Čedíková M.

Physiol Res. 2016 Dec 22;65(Supplementum 5):S633-S642.

19.

[Diabetic foot syndrome from the perspective of internist educated in podiatry].

Jirkovská A.

Vnitr Lek. 2016 Fall;62(11 Suppl 4):S42-47. Review. Czech.

PMID:
27921418
20.

Minor amputation does not negatively affect health-related quality of life as compared with conservative treatment in patients with a diabetic foot ulcer: An observational study.

Pickwell K, Siersma V, Kars M, Apelqvist J, Bakker K, Edmonds M, Holstein P, Jirkovská A, Jude EB, Mauricio D, Piaggesi A, Reike H, Spraul M, Uccioli L, Urbancic V, van Acker K, van Baal J, Schaper N.

Diabetes Metab Res Rev. 2017 Mar;33(3). doi: 10.1002/dmrr.2867. Epub 2016 Nov 30.

PMID:
27792855
21.

Cardioprotective effects of iron chelator HAPI and ROS-activated boronate prochelator BHAPI against catecholamine-induced oxidative cellular injury.

Hašková P, Jansová H, Bureš J, Macháček M, Jirkovská A, Franz KJ, Kovaříková P, Šimůnek T.

Toxicology. 2016 Sep 14;371:17-28. doi: 10.1016/j.tox.2016.10.004. Epub 2016 Oct 12.

22.

[Special contact splints in postoperative care for patients with the diabetic foot].

Fejfarová V, Jirkovská A, Bém R, Dubský M, Wosková V, Němcová A, Křížová M, Niklová J, Caňkářová O.

Rozhl Chir. Summer 2016;95(7):257-61. Review. Czech.

PMID:
27523173
23.

Corrigendum to: "Proteomic investigation of embryonic rat heart-derived H9c2 cell line sheds new light on the molecular phenotype of the popular cell model" [Exp. Cell Res. 339 2 (2015) 174-186].

Lenčo J, Lenčová-Popelová O, Link M, Jirkovská A, Tambor V, Potůčková E, Stulík J, Šimůnek T, Štěrba M.

Exp Cell Res. 2016 May 1;343(2):267. doi: 10.1016/j.yexcr.2016.02.007. Epub 2016 Apr 4. No abstract available.

PMID:
27155561
24.

Characterization of cytoprotective and toxic properties of iron chelator SIH, prochelator BSIH and their degradation products.

Jansová H, Bureš J, Macháček M, Hašková P, Jirkovská A, Roh J, Wang Q, Franz KJ, Kovaříková P, Šimůnek T.

Toxicology. 2016 Mar 28;350-352:15-24. doi: 10.1016/j.tox.2016.03.004. Epub 2016 Apr 1.

25.

Proteomic investigation of embryonic rat heart-derived H9c2 cell line sheds new light on the molecular phenotype of the popular cell model.

Lenčo J, Lenčová-Popelová O, Link M, Jirkovská A, Tambor V, Potůčková E, Stulík J, Šimůnek T, Štěrba M.

Exp Cell Res. 2015 Dec 10;339(2):174-86. doi: 10.1016/j.yexcr.2015.10.020. Epub 2015 Nov 5. Erratum in: Exp Cell Res. 2016 May 1;343 (2):267.

PMID:
26515555
26.

In Vitro Characterization of the Pharmacological Properties of the Anti-Cancer Chelator, Bp4eT, and Its Phase I Metabolites.

Potůčková E, Roh J, Macháček M, Sahni S, Stariat J, Šesták V, Jansová H, Hašková P, Jirkovská A, Vávrová K, Kovaříková P, Kalinowski DS, Richardson DR, Šimůnek T.

PLoS One. 2015 Oct 13;10(10):e0139929. doi: 10.1371/journal.pone.0139929. eCollection 2015.

27.

Impact of Inherited Prothrombotic Disorders on the Long-Term Clinical Outcome of Percutaneous Transluminal Angioplasty in Patients with Diabetes.

Dubský M, Jirkovská A, Pagáčová L, Bém R, Němcová A, Fejfarová V, Wosková V, Jude EB.

J Diabetes Res. 2015;2015:369758. doi: 10.1155/2015/369758. Epub 2015 Jul 13.

28.

Predictors of lower-extremity amputation in patients with an infected diabetic foot ulcer.

Pickwell K, Siersma V, Kars M, Apelqvist J, Bakker K, Edmonds M, Holstein P, Jirkovská A, Jude E, Mauricio D, Piaggesi A, Ragnarson Tennvall G, Reike H, Spraul M, Uccioli L, Urbancic V, van Acker K, van Baal J, Schaper N.

Diabetes Care. 2015 May;38(5):852-7. doi: 10.2337/dc14-1598. Epub 2015 Feb 9.

PMID:
25665817
29.

Comment on "Impact of diabetic foot on selected psychological or social characteristics".

Fejfarová V, Jirkovská A, Dragomirecká E, Game F, Bém R, Dubský M, Wosková V, Křížová M, Skibová J, Wu S.

J Diabetes Res. 2014;2014:246403. doi: 10.1155/2014/246403. Epub 2014 Oct 28. No abstract available.

30.

Structure-activity relationships of novel salicylaldehyde isonicotinoyl hydrazone (SIH) analogs: iron chelation, anti-oxidant and cytotoxic properties.

Potůčková E, Hrušková K, Bureš J, Kovaříková P, Špirková IA, Pravdíková K, Kolbabová L, Hergeselová T, Hašková P, Jansová H, Macháček M, Jirkovská A, Richardson V, Lane DJ, Kalinowski DS, Richardson DR, Vávrová K, Šimůnek T.

PLoS One. 2014 Nov 13;9(11):e112059. doi: 10.1371/journal.pone.0112059. eCollection 2014.

31.

Comparison of the effect of stem cell therapy and percutaneous transluminal angioplasty on diabetic foot disease in patients with critical limb ischemia.

Dubský M, Jirkovská A, Bem R, Fejfarová V, Pagacová L, Nemcová A, Sixta B, Chlupac J, Peregrin JH, Syková E, Jude EB.

Cytotherapy. 2014 Dec;16(12):1733-8. doi: 10.1016/j.jcyt.2014.08.010. Epub 2014 Oct 7.

PMID:
25304666
32.

Comparison of various iron chelators and prochelators as protective agents against cardiomyocyte oxidative injury.

Jansová H, Macháček M, Wang Q, Hašková P, Jirkovská A, Potůčková E, Kielar F, Franz KJ, Simůnek T.

Free Radic Biol Med. 2014 Sep;74:210-21. doi: 10.1016/j.freeradbiomed.2014.06.019. Epub 2014 Jun 30.

33.

Application of gentamicin-collagen sponge shortened wound healing time after minor amputations in diabetic patients - a prospective, randomised trial.

Varga M, Sixta B, Bem R, Matia I, Jirkovska A, Adamec M.

Arch Med Sci. 2014 May 12;10(2):283-7. doi: 10.5114/aoms.2014.42580. Epub 2014 May 13.

34.

Does the diabetic foot have a significant impact on selected psychological or social characteristics of patients with diabetes mellitus?

Fejfarová V, Jirkovská A, Dragomirecká E, Game F, Bém R, Dubský M, Wosková V, Křížová M, Skibová J, Wu S.

J Diabetes Res. 2014;2014:371938. doi: 10.1155/2014/371938. Epub 2014 Mar 25.

35.

Health-related quality of life predicts major amputation and death, but not healing, in people with diabetes presenting with foot ulcers: the Eurodiale study.

Siersma V, Thorsen H, Holstein PE, Kars M, Apelqvist J, Jude EB, Piaggesi A, Bakker K, Edmonds M, Jirkovská A, Mauricio D, Ragnarson Tennvall G, Reike H, Spraul M, Uccioli L, Urbancic V, van Acker K, van Baal J, Schaper NC.

Diabetes Care. 2014;37(3):694-700. doi: 10.2337/dc13-1212. Epub 2013 Oct 29.

PMID:
24170755
36.

Role of serum levels of angiogenic cytokines in assessment of angiogenesis after stem cell therapy of diabetic patients with critical limb ischemia.

Dubsky M, Jirkovska A, Bem R, Fejfarova V, Varga M, Kolesar L, Pagacova L, Sykova E, Jude EB.

Cell Transplant. 2014;23(12):1517-23. doi: 10.3727/096368913X674071. Epub 2013 Oct 21.

PMID:
24148204
37.

Importance of factors determining the low health-related quality of life in people presenting with a diabetic foot ulcer: the Eurodiale study.

Siersma V, Thorsen H, Holstein PE, Kars M, Apelqvist J, Jude EB, Piaggesi A, Bakker K, Edmonds M, Jirkovska A, Mauricio D, Ragnarson Tennvall G, Reike H, Spraul M, Uccioli L, Urbancic V, van Acker K, van Baal J, Schaper NC.

Diabet Med. 2013 Nov;30(11):1382-7. doi: 10.1111/dme.12254. Epub 2013 Jul 15.

PMID:
23758490
38.

Both autologous bone marrow mononuclear cell and peripheral blood progenitor cell therapies similarly improve ischaemia in patients with diabetic foot in comparison with control treatment.

Dubsky M, Jirkovska A, Bem R, Fejfarova V, Pagacova L, Sixta B, Varga M, Langkramer S, Sykova E, Jude EB.

Diabetes Metab Res Rev. 2013 Jul;29(5):369-76. doi: 10.1002/dmrr.2399.

PMID:
23390092
39.

Risk factors for recurrence of diabetic foot ulcers: prospective follow-up analysis in the Eurodiale subgroup.

Dubský M, Jirkovská A, Bem R, Fejfarová V, Skibová J, Schaper NC, Lipsky BA.

Int Wound J. 2013 Oct;10(5):555-61. doi: 10.1111/j.1742-481X.2012.01022.x. Epub 2012 Jun 19.

PMID:
22712631
40.

Nanofibers prepared by needleless electrospinning technology as scaffolds for wound healing.

Dubský M, Kubinová S, Sirc J, Voska L, Zajíček R, Zajícová A, Lesný P, Jirkovská A, Michálek J, Munzarová M, Holáň V, Syková E.

J Mater Sci Mater Med. 2012 Apr;23(4):931-41. doi: 10.1007/s10856-012-4577-7. Epub 2012 Feb 14.

PMID:
22331377
41.
42.

The Charcot foot in diabetes.

Rogers LC, Frykberg RG, Armstrong DG, Boulton AJ, Edmonds M, Van GH, Hartemann A, Game F, Jeffcoate W, Jirkovska A, Jude E, Morbach S, Morrison WB, Pinzur M, Pitocco D, Sanders L, Wukich DK, Uccioli L.

J Am Podiatr Med Assoc. 2011 Sep-Oct;101(5):437-46. Review.

PMID:
21957276
43.

The Charcot foot in diabetes.

Rogers LC, Frykberg RG, Armstrong DG, Boulton AJ, Edmonds M, Van GH, Hartemann A, Game F, Jeffcoate W, Jirkovska A, Jude E, Morbach S, Morrison WB, Pinzur M, Pitocco D, Sanders L, Wukich DK, Uccioli L.

Diabetes Care. 2011 Sep;34(9):2123-9. doi: 10.2337/dc11-0844.

44.

[Treatment of critical limb ischemia and diabetic foot disease by the use of autologous stem cells].

Dubský M, Jirkovská A, Bém R, Pagácová L, Fejfarová V, Varga M, Skibová J, Langkramer S, Syková E.

Vnitr Lek. 2011 May;57(5):451-5. Czech.

PMID:
21695925
45.

Differences in minor amputation rate in diabetic foot disease throughout Europe are in part explained by differences in disease severity at presentation.

van Battum P, Schaper N, Prompers L, Apelqvist J, Jude E, Piaggesi A, Bakker K, Edmonds M, Holstein P, Jirkovska A, Mauricio D, Ragnarson Tennvall G, Reike H, Spraul M, Uccioli L, Urbancic V, van Acker K, van Baal J, Ferreira I, Huijberts M.

Diabet Med. 2011 Feb;28(2):199-205. doi: 10.1111/j.1464-5491.2010.03192.x.

PMID:
21219430
46.

Role of quantitative bone scanning in the assessment of bone turnover in patients with Charcot foot.

Bem R, Jirkovská A, Dubsky M, Fejfarová V, Buncová M, Skibová J, Jude EB.

Diabetes Care. 2010 Feb;33(2):348-9. doi: 10.2337/dc09-0950. Epub 2009 Nov 23.

47.

Modified orthostatic load for spectral analysis of short-term heart rate variability improves the sensitivity of autonomic dysfunction assessment.

Howorka K, Pumprla J, Jirkovska A, Lacigova S, Nolan J.

J Diabetes Complications. 2010 Jan-Feb;24(1):48-54. doi: 10.1016/j.jdiacomp.2008.10.003. Epub 2008 Dec 5.

PMID:
19062311
48.

Resource utilisation and costs associated with the treatment of diabetic foot ulcers. Prospective data from the Eurodiale Study.

Prompers L, Huijberts M, Schaper N, Apelqvist J, Bakker K, Edmonds M, Holstein P, Jude E, Jirkovska A, Mauricio D, Piaggesi A, Reike H, Spraul M, Van Acker K, Van Baal S, Van Merode F, Uccioli L, Urbancic V, Ragnarson Tennvall G.

Diabetologia. 2008 Oct;51(10):1826-34. doi: 10.1007/s00125-008-1089-6. Epub 2008 Jul 22.

PMID:
18648766
49.

[Education of diabetic patients with chronic kidney disease and after transplantation].

Jirkovská A.

Vnitr Lek. 2008 May;54(5):530-4. Review. Czech.

PMID:
18630641
50.

Delivery of care to diabetic patients with foot ulcers in daily practice: results of the Eurodiale Study, a prospective cohort study.

Prompers L, Huijberts M, Apelqvist J, Jude E, Piaggesi A, Bakker K, Edmonds M, Holstein P, Jirkovska A, Mauricio D, Tennvall GR, Reike H, Spraul M, Uccioli L, Urbancic V, Van Acker K, Van Baal J, Van Merode F, Schaper N.

Diabet Med. 2008 Jun;25(6):700-7. doi: 10.1111/j.1464-5491.2008.02445.x.

PMID:
18544108

Supplemental Content

Loading ...
Support Center